IPP Bureau
Strides launches Icosapent Ethyl Acid Soft Gel capsules in partnership with Amneal
By IPP Bureau - December 02, 2023
The product has been in-licensed from Strides and will be commercialized by Amneal
USFDA inspection at Alkem Laboratories API manufacturing facility located at Mandva
By IPP Bureau - December 02, 2023
The company has received Form 483 with three observations
Biocon Biologics completes Integration of Viatris' Biosimilar business
By IPP Bureau - December 01, 2023
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Eugia Pharma receives USFDA approval for Budesonide Inhalation Suspension
By IPP Bureau - December 01, 2023
The product is expected to be launched in FY25
Cipla partners with TEACH to create career opportunities for hearing-impaired youth
By IPP Bureau - December 01, 2023
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
New global survey finds widespread misunderstandings about shingles despite its lifetime prevalence
By IPP Bureau - December 01, 2023
A new GSK survey shows a large number of adults do not understand how shingles may be triggered
CPHI & PMEC India 2023 redefines pharma landscape
By IPP Bureau - November 30, 2023
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
Cadila launches Rs. 200 crore API facility in Dahej
By IPP Bureau - November 30, 2023
Equipped with most advanced Distributed Control System (DCS) automation technology, the facility has been set up with an investment of Rs. 200 crore
Dupixent significantly reduced COPD exacerbations in second positive Phase 3 trial
By IPP Bureau - November 29, 2023
Accelerating FDA submission and confirming potential to become first approved biologic for this serious disease
Roche expands hepatitis diagnostics portfolio
By IPP Bureau - November 29, 2023
Almost 300 million people globally have chronic hepatitis B
Bayer commits to Veeva Vault CRM and Veeva OpenData globally
By IPP Bureau - November 29, 2023
Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data
Aster to separate its India and GCC businesses to unlock value
By IPP Bureau - November 29, 2023
Both the India and GCC entities will be operated by separate dedicated management teams
Aurobindo Pharma receives USFDA approval for Darunavir Tablets
By IPP Bureau - November 29, 2023
BrainSpec receives FDA clearance to begin using AI-backed solution for non-invasive brain chemistry measurement
By IPP Bureau - November 28, 2023
First-ever brain chemistry database will allow clinicians to quickly infer brain biomarker data to support the diagnostic process in conditions such as Alzheimer's Disease
